About Astrana Health, Inc.
https://www.astranahealth.comAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement.
CEO
Brandon K. Sim
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Care Facilities
Sector Healthcare
Went public March 11, 2009
Method of going public Reverse Merger
Full time employees 1,900
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-04-27 | Reverse | 1:10 |
| 2007-11-26 | Reverse | 1:136 |
ETFs Holding This Stock
Summary
Total 78
Showing Top 3 of 78
Ratings Snapshot
Rating : B-
Discounted Cash Flow 5
Return On Equity 2
Return On Assets 3
Debt To Equity 1
Price To Earnings 1
Price To Book 3
Overall Score 3
Most Recent Analyst Grades
Grade Summary
Buy 6
Outperform 1
Equal Weight 1
Showing Top 6 of 8
Price Target
Target High $37
Target Low $26
Target Median $28
Target Consensus $30.33
Market Cap $1.37 B
52w High $39.97
52w Low $20.12
P/E 144.11
Volume 379.63K
Outstanding Shares 50.16M
About Astrana Health, Inc.
https://www.astranahealth.comAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $956.05M ▲ | $62.39M ▲ | $373K ▼ | 0.04% ▼ | $-0.33 ▼ | $38.98M ▲ |
| Q2-2025 | $654.81M ▲ | $57.63M ▲ | $9.42M ▲ | 1.44% ▲ | $0.19 ▲ | $31.11M ▲ |
| Q1-2025 | $620.39M ▼ | $50.75M ▼ | $6.69M ▲ | 1.08% ▲ | $0.14 ▲ | $23.76M ▲ |
| Q4-2024 | $665.21M ▲ | $62.3M ▲ | $-6.95M ▼ | -1.04% ▼ | $-0.14 ▼ | $14.3M ▼ |
| Q3-2024 | $478.71M | $45.07M | $16.09M | 3.36% | $0.34 | $42.93M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $463.45M ▲ | $2.24B ▲ | $1.68B ▲ | $775.54M ▲ |
| Q2-2025 | $342.12M ▲ | $1.44B ▲ | $904.4M ▲ | $765.46M ▲ |
| Q1-2025 | $260.91M ▼ | $1.33B ▼ | $813.55M ▼ | $745.37M ▲ |
| Q4-2024 | $290.83M ▼ | $1.35B ▲ | $840.73M ▲ | $712.72M ▲ |
| Q3-2024 | $350.35M | $1.29B | $778.27M | $704.62M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $373K ▼ | $9.96M ▼ | $-534.47M ▼ | $648.49M ▲ | $122.52M ▲ | $7.4M ▼ |
| Q2-2025 | $9.42M ▲ | $90.9M ▲ | $-1.05M ▲ | $-8.67M ▲ | $81.19M ▲ | $89.48M ▲ |
| Q1-2025 | $6.22M ▲ | $16.63M ▲ | $-2.39M ▲ | $-44.17M ▼ | $-29.94M ▲ | $13.56M ▲ |
| Q4-2024 | $-7.78M ▼ | $-10.95M ▼ | $-33.32M ▼ | $-15.27M ▼ | $-59.54M ▼ | $-13.48M ▼ |
| Q3-2024 | $23.7M | $33.98M | $-8.11M | $-3.19M | $22.68M | $31.69M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Health Care Capitation Revenue | $430.00M ▲ | $980.00M ▲ | $580.00M ▼ | $610.00M ▲ |
 Health Care Other | $20.00M ▲ | $50.00M ▲ | $10.00M ▼ | $20.00M ▲ |
 Health Care Patient Service | $20.00M ▲ | $20.00M ▲ | $10.00M ▼ | $20.00M ▲ |
 Management Service | $0 ▲ | $10.00M ▲ | $0 ▼ | $0 ▲ |
 Product and Service Other | $0 ▲ | $10.00M ▲ | $0 ▼ | $0 ▲ |
CEO
Brandon K. Sim
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Medical - Care Facilities
Sector Healthcare
Went public March 11, 2009
Method of going public Reverse Merger
Full time employees 1,900
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-04-27 | Reverse | 1:10 |
| 2007-11-26 | Reverse | 1:136 |
ETFs Holding This Stock
Summary
Total 78
Showing Top 3 of 78
Ratings Snapshot
Rating : B-
Discounted Cash Flow 5
Return On Equity 2
Return On Assets 3
Debt To Equity 1
Price To Earnings 1
Price To Book 3
Overall Score 3
Most Recent Analyst Grades
Grade Summary
Buy 6
Outperform 1
Equal Weight 1
Showing Top 6 of 8
Price Target
Target High $37
Target Low $26
Target Median $28
Target Consensus $30.33